Jeffrey Blizard - 28 May 2025 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Director
Signature
/s/ Megan Smeykal, Attorney-in-fact
Issuer symbol
TELA
Transactions as of
28 May 2025
Net transactions value
$0
Form type
4
Filing time
30 May 2025, 16:17:10 UTC
Previous filing
07 Apr 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Blizard Jeffrey Director C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN /s/ Megan Smeykal, Attorney-in-fact 30 May 2025 0002012926

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +7,950 +125% $0.000000 14,325 28 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +11,700 $0.000000 11,700 28 May 2025 Common Stock 11,700 $1.39 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
F2 The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.